PHARMACEUTICAL RESEARCH IN MOLECULAR ONCOLOGY

被引：115

作者：

GIBBS, JB

OLIFF, A

机构：

[1] Department of Cancer Research Merck Research Laboratories West Point

来源：

CELL | 1994年 / 79卷 / 02期

关键词：

D O I：

10.1016/0092-8674(94)90189-9

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

[No abstract available]

引用

收藏

页码：193 / 198

页数：6

相关论文

共 40 条

[1] ONCOGENIC ACTIVITY OF THE C-MYC PROTEIN REQUIRES DIMERIZATION WITH MAX
AMATI, B
BROOKS, MW
LEVY, N
LITTLEWOOD, TD
EVAN, GI
LAND, H
[J]. CELL, 1993, 72 (02) : 233 - 245
[2] MOLECULAR THEMES IN ONCOGENESIS
BISHOP, JM
[J]. CELL, 1991, 64 (02) : 235 - 248
[3] 4,5-DIANILINOPHTHALIMIDE - A PROTEIN-TYROSINE KINASE INHIBITOR WITH SELECTIVITY FOR THE EPIDERMAL GROWTH-FACTOR RECEPTOR SIGNAL-TRANSDUCTION PATHWAY AND POTENT IN-VIVO ANTITUMOR-ACTIVITY
BUCHDUNGER, E
TRINKS, U
METT, H
REGENASS, U
MULLER, M
MEYER, T
MCGLYNN, E
PINNA, LA
TRAXLER, P
LYDON, NB
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (06) : 2334 - 2338
[4] CRYSTAL-STRUCTURE OF A P53 TUMOR-SUPPRESSOR DNA COMPLEX - UNDERSTANDING TUMORIGENIC MUTATIONS
CHO, YJ
GORINA, S
JEFFREY, PD
PAVLETICH, NP
[J]. SCIENCE, 1994, 265 (5170) : 346 - 355
[5] CREEKMORE S, 1992, P AN M AM SOC CLIN, V11, P345
[6] GENE-THERAPY FOR CANCER
CULVER, KW
BLAESE, RM
[J]. TRENDS IN GENETICS, 1994, 10 (05) : 174 - 178
[7] FOS AND JUN - THE AP-1 CONNECTION
CURRAN, T
FRANZA, BR
[J]. CELL, 1988, 55 (03) : 395 - 397
[8] DEVITA VT, 1993, CANCER PRINCIPLES PR
[9] THE PATHWAY TO SIGNAL ACHIEVEMENT
EGAN, SE
WEINBERG, RA
[J]. NATURE, 1993, 365 (6449) : 781 - 783
[10] RECOGNITION BY MAX OF ITS COGNATE DNA THROUGH A DIMERIC B/HLH/Z DOMAIN
FERREDAMARE, AR
PRENDERGAST, GC
ZIFF, EB
BURLEY, SK
[J]. NATURE, 1993, 363 (6424) : 38 - 45

← 1 2 3 4 →